We are live on
!
Find out more
PP
Paloma Partners Portfolio holdings
AUM
$510M
1-Year Est. Return
286.05%
This Fund
S&P 500
This Quarter
Est. Return
+3.59%
1 Year Est. Return
+286.05%
3 Year Est. Return
+321.92%
5 Year Est. Return
+284.54%
10 Year Est. Return
+855.7%
AUM
$10.2B
AUM Growth
+$2.21B
(+28%)
Cap. Flow
+$1.91B
Cap. Flow
% of AUM
18.7%
Top 10 Holdings %
Top 10 Hldgs %
42.15%
Holding
2,326
New
523
Increased
761
Reduced
552
Closed
381
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Biogen
BIIB
|
+$88.6M |
| 2 |
Invesco QQQ Trust
QQQ
|
+$55.2M |
| 3 |
Amazon
AMZN
|
+$50.7M |
| 4 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$50.4M |
| 5 |
Apple
AAPL
|
+$27.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
KLA
KLAC
|
+$30.4M |
| 2 |
Wells Fargo
WFC
|
+$18.1M |
| 3 |
State Street SPDR S&P Oil & Gas Exploration & Production ETF
XOP
|
+$13.9M |
| 4 |
STJ
St Jude Medical
STJ
|
+$13.5M |
| 5 |
LNKD
LinkedIn Corporation
LNKD
|
+$13.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 4.46% |
| 2 | Industrials | 3.74% |
| 3 | Financials | 3.69% |
| 4 | Healthcare | 3.55% |
| 5 | Technology | 3.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
TBI
1526
Trueblue
TBI
$235M
| $468K | ﹤0.01% |
+18,977
| New | +$400K |
|
1527
Valmont Industries
VMI
$9.33B
| $468K | ﹤0.01% |
+3,318
| New | +$461K |
|
1528
Workday
WDAY
$39.4B
| $467K | ﹤0.01% |
7,060
-1,500
| -18% | -$121K |
|
|
BCR
1529
DELISTED
CR Bard Inc.
BCR
| $463K | ﹤0.01% |
2,062
-4,309
| -68% | -$936K |
|
|
HZNP
1530
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $462K | ﹤0.01% |
+28,571
| New | +$518K |
|
|
VRE
1531
DELISTED
Veris Residential
VRE
| $460K | ﹤0.01% |
15,843
-1,109
| -7% | -$29.7K |
|
1532
KeyCorp
KEY
$24.3B
| $459K | ﹤0.01% |
25,113
-33,669
| -57% | -$531K |
|
|
RGC
1533
DELISTED
Regal Entertainment Group
RGC
| $458K | ﹤0.01% |
+22,254
| New | +$494K |
|
|
HES
1534
DELISTED
Hess
HES
| $453K | ﹤0.01% |
7,268
+1,066
| +17% | +$58.3K |
|
1535
Hubbell
HUBB
$25.6B
| $453K | ﹤0.01% |
+3,878
| New | +$426K |
|
1536
Lindsay Corp
LNN
$1.17B
| $453K | ﹤0.01% |
+6,080
| New | +$482K |
|
1537
Sibanye-Stillwater
SBSW
$5.93B
| $453K | ﹤0.01% |
67,964
+44,902
| +195% | +$409K |
|
|
ABMD
1538
DELISTED
Abiomed Inc
ABMD
| $453K | ﹤0.01% |
+4,020
| New | +$466K |
|
1539
Carlisle Companies
CSL
$14.1B
| $452K | ﹤0.01% |
4,097
-16,709
| -80% | -$1.82M |
|
1540
Choice Hotels
CHH
$5.22B
| $451K | ﹤0.01% |
8,028
-19,443
| -71% | -$975K |
|
1541
Vail Resorts
MTN
$5.6B
| $451K | ﹤0.01% |
2,798
-3,412
| -55% | -$542K |
|
|
RPAI
1542
DELISTED
RETAIL PROPERTIES OF AMERICA, INC.
RPAI
| $451K | ﹤0.01% |
+29,408
| New | +$453K |
|
|
SFR
1543
DELISTED
Starwood Waypoint Homes
SFR
| $450K | ﹤0.01% |
15,616
-21,990
| -58% | -$639K |
|
1544
Genuine Parts
GPC
$17.9B
| $449K | ﹤0.01% |
+4,704
| New | +$449K |
|
1545
Grand Canyon Education
LOPE
$3.99B
| $449K | ﹤0.01% |
+7,677
| New | +$393K |
|
1546
Pitney Bowes
PBI
$2.41B
| $449K | ﹤0.01% |
29,535
-26,694
| -47% | -$425K |
|
|
VSM
1547
DELISTED
Versum Materials, Inc.
VSM
| $448K | ﹤0.01% |
+15,968
| New | +$398K |
|
1548
Forum Energy Technologies
FET
$593M
| $447K | ﹤0.01% |
1,016
-1,151
| -53% | -$481K |
|
1549
Algonquin Power & Utilities
AQN
$4.68B
| $446K | ﹤0.01% |
+52,600
| New | +$445K |
|
1550
CRH
CRH
$69.1B
| $445K | ﹤0.01% |
12,936
-9,029
| -41% | -$301K |
|
Similar funds
PWMG
NIEF
HIM
MCA
OA
MC
CTAF
MWAM
Paloma Partners's Q4 2016 Portfolio in Review
As of Q4 2016, Paloma Partners held 2,326 positions worth $10.2B, up 28% from $7.99B the previous quarter. Its ten largest holdings account for 42% of the portfolio.
Paloma Partners deployed $1.91B of net new capital in Q4 2016, opening 523 new positions and adding to 761 existing holdings. Its largest new stake was NXP Semiconductors: 253,000 shares worth $24.8M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 4.5% of assets, up from 3.4% a quarter earlier, followed by Industrials and Financials.
On the sell side, the largest reduction was KLA, an estimated $30.4M trimmed.
- Paloma Partners's largest Q4 2016 buy was NXP Semiconductors: 253,000 shares worth $24.8M.
- Paloma Partners added most to Biogen in Q4 2016, an estimated $88.6M increase.
- Paloma Partners's biggest Q4 2016 reduction was KLA, cutting an estimated $30.4M.
- Paloma Partners fully exited St Jude Medical in Q4 2016, selling an estimated $13.5M.
- Paloma Partners's ten largest holdings make up 42% of its $10.2B portfolio in Q4 2016.
- Paloma Partners opened 523 new positions and closed 381 in Q4 2016.
- Paloma Partners's portfolio value rose 28% quarter-over-quarter to $10.2B.
Based on Paloma Partners's 13F filing for Q4 2016, filed 14 Feb 2017.